Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 06-2012 | 03-2012 | 12-2011 | 09-2011 | 06-2011 | |
| Sales | 48 | 31 | 24 | 0 | 0 |
| Gross Profit | 48 | 31 | 24 | N/A | N/A |
| Operating Expenses | 6,851 | 4,900 | 4,063 | 2,913 | 1,770 |
| Operating Income | -6,803 | -4,869 | -4,039 | -2,913 | -1,770 |
| Other Income | -1,437 | -715 | 1,352 | -34 | -175 |
| Pre-tax Income | -8,240 | -5,584 | -2,687 | -2,947 | -1,945 |
| Net Income Continuous | -8,240 | -5,584 | -2,687 | -2,947 | -1,945 |
| Net Income Discontinuous | 1 | -1 | 0 | 0 | -69 |
| Minority Interests | -248 | -249 | -201 | -170 | -194 |
| Net Income | $-7,992 | $-5,335 | $-2,486 | $-2,777 | $-1,820 |
| EPS Basic Total Ops | -0.71 | -0.50 | -0.25 | -0.39 | -0.25 |
| EPS Basic Continuous Ops | -0.71 | -0.50 | -0.25 | -0.39 | -0.24 |
| EPS Basic Discontinuous Ops | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| EPS Diluted Total Ops | -0.71 | -0.50 | -0.25 | -0.36 | -0.25 |
| EPS Diluted Continuous Ops | -0.71 | -0.50 | -0.25 | -0.41 | -0.24 |
| EPS Diluted Discontinuous Ops | 0.00 | 0.00 | 0.00 | 0.05 | -0.01 |
| EBITDA(a) | $-6,406 | $-4,442 | $-3,581 | $-2,843 | $-1,732 |